Early, reversible plasma membrane injury in galactosamine-induced liver cell death. 1975

S K El-Mofty, and M C Scrutton, and A Serroni, and C Nicolini, and J L Farber

Administration to rats of D-galactosamine (400 mg/kg) produces liver cell death that develops during the first 24 hours. Plasma membranes isolated within the first few hours from these animals show a 40% reduction in 5'-nucleotidase activity and a two-fold increase in maximum negative ellipticity determined by circular dichroism. Simultaneous administration of uridine prevents liver cell death and these early alterations in the plasma membranes. Uridine also prevents cell death if administered for up to 3 hours after galactosamine. The 5'nucleotidase activity reduced when uridine is administered for up to 2-1/2 hours after galactosamine. Changes in the liver calcium ion concentration accompany these plasma membrane alterations. Uridine will prevent and reverse the changes in calcium content in parallel to its ability to reverse the membrane alterations. The significance of these findings with respect to the mechanism of galactosamine-induced liver cell death is discussed.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009708 Nucleotidases A class of enzymes that catalyze the conversion of a nucleotide and water to a nucleoside and orthophosphate. EC 3.1.3.-.
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002942 Circular Dichroism A change from planar to elliptic polarization when an initially plane-polarized light wave traverses an optically active medium. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Circular Dichroism, Vibrational,Dichroism, Circular,Vibrational Circular Dichroism
D003300 Copper A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55. Copper-63,Copper 63
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response

Related Publications

S K El-Mofty, and M C Scrutton, and A Serroni, and C Nicolini, and J L Farber
January 1972, Progress in liver diseases,
S K El-Mofty, and M C Scrutton, and A Serroni, and C Nicolini, and J L Farber
January 2005, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy,
S K El-Mofty, and M C Scrutton, and A Serroni, and C Nicolini, and J L Farber
January 1979, Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
S K El-Mofty, and M C Scrutton, and A Serroni, and C Nicolini, and J L Farber
October 1988, Gastroenterologia Japonica,
S K El-Mofty, and M C Scrutton, and A Serroni, and C Nicolini, and J L Farber
January 1977, Acta morphologica Academiae Scientiarum Hungaricae,
S K El-Mofty, and M C Scrutton, and A Serroni, and C Nicolini, and J L Farber
January 1984, Acta morphologica Hungarica,
S K El-Mofty, and M C Scrutton, and A Serroni, and C Nicolini, and J L Farber
January 2019, Advances in pharmacology (San Diego, Calif.),
S K El-Mofty, and M C Scrutton, and A Serroni, and C Nicolini, and J L Farber
April 1973, Federation proceedings,
S K El-Mofty, and M C Scrutton, and A Serroni, and C Nicolini, and J L Farber
September 1980, Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
S K El-Mofty, and M C Scrutton, and A Serroni, and C Nicolini, and J L Farber
December 2007, American journal of physiology. Gastrointestinal and liver physiology,
Copied contents to your clipboard!